[go: up one dir, main page]

FR2841156B1 - Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant - Google Patents

Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant

Info

Publication number
FR2841156B1
FR2841156B1 FR0207545A FR0207545A FR2841156B1 FR 2841156 B1 FR2841156 B1 FR 2841156B1 FR 0207545 A FR0207545 A FR 0207545A FR 0207545 A FR0207545 A FR 0207545A FR 2841156 B1 FR2841156 B1 FR 2841156B1
Authority
FR
France
Prior art keywords
particles
conjugates
diagnostic
therapeutic
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0207545A
Other languages
English (en)
Other versions
FR2841156A1 (fr
Inventor
Abdelhamid Elaissari
Thierry Delair
Raphael Veyret
Bernard Mandrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Priority to FR0207545A priority Critical patent/FR2841156B1/fr
Priority to AU2003260611A priority patent/AU2003260611A1/en
Priority to PCT/FR2003/001884 priority patent/WO2004001414A1/fr
Publication of FR2841156A1 publication Critical patent/FR2841156A1/fr
Application granted granted Critical
Publication of FR2841156B1 publication Critical patent/FR2841156B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR0207545A 2002-06-19 2002-06-19 Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant Expired - Fee Related FR2841156B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0207545A FR2841156B1 (fr) 2002-06-19 2002-06-19 Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant
AU2003260611A AU2003260611A1 (en) 2002-06-19 2003-06-19 Fluorescent magnetic nanoparticles
PCT/FR2003/001884 WO2004001414A1 (fr) 2002-06-19 2003-06-19 Nanoparticules magnetiques fluorescentes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0207545A FR2841156B1 (fr) 2002-06-19 2002-06-19 Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant

Publications (2)

Publication Number Publication Date
FR2841156A1 FR2841156A1 (fr) 2003-12-26
FR2841156B1 true FR2841156B1 (fr) 2004-09-10

Family

ID=29719860

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0207545A Expired - Fee Related FR2841156B1 (fr) 2002-06-19 2002-06-19 Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant

Country Status (3)

Country Link
AU (1) AU2003260611A1 (fr)
FR (1) FR2841156B1 (fr)
WO (1) WO2004001414A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312479C (zh) 2003-08-08 2007-04-25 清华大学 一种纳米荧光磁粒及其制备方法
EP1718341A2 (fr) * 2004-01-20 2006-11-08 Alnis Biosciences, Inc. Articles comprenant un materiau magnetique et des agents bioactifs
US20110262415A1 (en) * 2008-12-21 2011-10-27 Cnr - Consiglio Nazionale Delle Ricerche Erythrocyte-based delivery system, method of preparation and uses thereof
JP5317899B2 (ja) * 2009-09-11 2013-10-16 富士フイルム株式会社 ラテックス粒子を用いた免疫アッセイ方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69029908T2 (de) * 1989-12-14 1997-05-22 Dade International Inc., Deerfield, Ill. Magnetische und fluoreszierende polymerteilchen und ihre anwendung
EP0882232A1 (fr) * 1996-08-23 1998-12-09 Amcell Corporation Detection sensible de marqueurs de surface de cellules sur des cellules viables
IL139638A0 (en) * 1998-05-26 2002-02-10 Univ Bar Ilan Nucleation and growth of magnetic metal oxide nanoparticles and its use
AU3347900A (en) * 1999-01-23 2000-08-07 Minerva Biotechnologies Corporation Interaction of colloid-immobilized species with species on non-colloidal structures
AU4324900A (en) * 1999-02-05 2000-08-25 University Of Maryland At Baltimore Luminescence spectral properties of cds nanoparticles
WO2001073117A1 (fr) * 2000-03-31 2001-10-04 MEMOREC STOFFEL GmbH - MEDIZINISCH-MOLEKULARE ENTWICKLUNG, KÖLN Utilisation de particules, aptes a transmettre des signaux et possedant au moins un groupe d'affinite pour les acides nucleiques marques
WO2001078087A2 (fr) * 2000-04-06 2001-10-18 Luminex Corporation Microbilles a reaction magnetique
ATE319087T1 (de) * 2000-06-21 2006-03-15 Bioarray Solutions Ltd Multianalytische molekularanalyse durch verwendung anwendungsspezifischer zufallspartikelarrays
AU2001281248A1 (en) * 2000-08-11 2002-03-13 Nanosphere Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor

Also Published As

Publication number Publication date
FR2841156A1 (fr) 2003-12-26
WO2004001414A1 (fr) 2003-12-31
AU2003260611A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
EP2322200A3 (fr) Les compositions et les methodes pour le traitement de maladies liées immunisées
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
WO2004001019A3 (fr) Nouvelles nanoparticules et leur utilisation
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
WO2003088808A3 (fr) Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
MXPA05005107A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
EP2500438A3 (fr) Compositions et procédés nouveaux pour le traitement du psoriasis
WO2004024097A8 (fr) Compositions et methodes de traitement de maladies de nature immune
FR2842201B1 (fr) Nouvel oligosaccharide, compositions cosmetiques et/ou dermatologiques en contenant et ses applications
EP1389970A4 (fr) Compositions et methodes permettant un double ciblage d'infections virales et de cellules cancereuses
DE60111430D1 (de) Hypochlorige säure zusammensetzung und ihre verwendungen
EP2067472A8 (fr) Compositions et procédés pour le traitement et le diagnostic d'une tumeur
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
ATE416754T1 (de) Mukoadhäsive zusammensetzung mit polyacrylat und einem chemolockstoff
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
DE60033649D1 (de) Verbindungen und therapeutische methoden
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
WO2004024064A8 (fr) Compositions et methodes de diagnostic et de traitement de tumeurs
WO2006110760A3 (fr) Compositions et methodes de diagnostic et de traitement de tumeur
WO2004067564A3 (fr) Compositions contre l'antgene cancereux liv-1 et leurs utilisations
FR2841156B1 (fr) Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060228